GST Refund for Pharma under Inverted Duty Structure: Rule 89(5) Application

A mid-sized Indian formulator in Hyderabad closes March books and pulls the GST inverted-duty file: ₹120 crore formulation turnover for the year, ₹86 crore of API and excipient purchases at 18%, formulations sold at 12%, and a ₹2.4 crore refund claim under Rule 89(5) sitting across four quarterly RFD-01 filings — two sanctioned, one provisionally sanctioned with a partial disallowance, and one stuck on a deficiency memo. The pattern is structural for any GST refund inverted duty pharma Rule 89(5) India operation that books APIs at 18% and dispatches finished formulations at 12%. The reconciliation, the formula, and the procedural overlay each need their own discipline.

Quick reference

Why the inverted duty structure exists in pharma

The GST rate matrix places most active pharmaceutical ingredients in HSN chapter 29 at 18% — the standard chemical-intermediate rate — while finished formulations in HSN 3003 and 3004 sit at 12% as essential medicaments. A small set of life-saving formulations sit at 5% or are exempt entirely (cancer drugs, ORS, specified vaccines), which compounds the inversion. Excipients, packaging materials, lab consumables and printed cartons mostly carry 18% or 12%, but the dominant input value is the API. A typical generic formulator’s monthly cost stack has APIs and excipients at 60-70% of manufacturing cost, of which 70-85% is APIs procured at 18%. Selling output at 12% means the input tax availed runs structurally ahead of the output tax liability every month, and the gap accumulates as unutilised ITC in the electronic credit ledger.

Without the inverted-duty refund route, this ITC sits idle on the balance sheet. Rule 89(5) is the prescribed mechanism to convert that idle balance back into cash — but only the portion attributable to inputs, computed under a specific formula, subject to procedural compliance, and bounded by a 2-year limitation.

The Rule 89(5) formula, decoded

The formula prescribed in Rule 89(5) (as amended) for the maximum refund of unutilised ITC under inverted duty structure is:

Maximum Refund Amount = [(Turnover of Inverted-rated Supply of Goods × Net ITC) ÷ Adjusted Total Turnover] − Tax payable on such inverted-rated supply of goods

Each term carries specific meaning that the GSTR-3B, GSTR-2B and RFD-01 reconciliation must respect:

• Net ITC — ITC availed on inputs during the relevant period. Excludes ITC on input services and capital goods in the original 2017 form; the post-July 2022 amendment introduced a proportional netting for input services such that the refundable amount is effectively reduced by a turnover-weighted share. ITC on capital goods stays excluded outright.
• Turnover of Inverted-rated Supply of Goods — the value of supplies that bear an output rate lower than the input rate. For a formulator, this is the 12% formulation supply pool.
• Adjusted Total Turnover — total turnover in the state for the period, excluding exempt supplies (other than zero-rated) and turnover of services. Deemed-export legs where the supplier claims the refund are excluded.
• Tax payable on such inverted-rated supply — the actual GST liability on the 12% formulation supply, as reported in GSTR-3B Table 3.1.

For a clean reconciliation, the books must reproduce all four lines independently and tie back to the GST returns before the RFD-01 is locked.

Filing flow: RFD-01 to RFD-06

The procedural chain runs across multiple forms and acknowledgement statuses:

1. RFD-01 — refund application filed on the GST portal with statement 1 (formula computation) and statement 1A (HSN-wise inverted-rated supply and Net ITC details).
2. RFD-02 — system-generated acknowledgement when the application clears the initial scrutiny, typically within 15 days.
3. RFD-03 — deficiency memo if the application is incomplete. The original application is treated as not filed; a fresh RFD-01 must be filed after rectification, with the 2-year limitation clock continuing to run.
4. RFD-04 — provisional refund (90% of the claim) for exporters within 7 days; not the default route for inverted-duty refunds, but available in specific cases.
5. RFD-06 — final sanction or rejection order from the proper officer.
6. RFD-05 — payment order, the trigger for the actual bank credit.

A reconciliation control logs every application by ARN, tracks the form trail through the chain, ages each pending application against the limitation runway, and ties the sanctioned amount to the bank credit when it arrives.

Worked example — ₹120 crore formulation manufacturer

A formulator with three plants in Telangana and Maharashtra, ₹120 crore annual formulation turnover at 12% GST, ₹86 crore annual API and excipient purchases predominantly at 18%, and a mixed export/domestic split:

• Domestic formulation supply at 12%: ₹95 crore (the inverted-rated supply pool)
• Export of formulations at zero-rated (with LUT): ₹20 crore (separate Rule 89(4) refund route)
• Domestic 5% life-saving formulation supply: ₹5 crore (excluded from inverted-rated pool as it is a different sub-pool but typically treated separately per the rate-specific RFD-01 line)
• Total inputs ITC for the year (Net ITC after capital-goods and input-services netting): ₹13.5 crore approx
• Adjusted Total Turnover for the year: ₹120 crore
• Tax payable on inverted-rated supply at 12% on ₹95 crore: ₹11.4 crore

Applying the formula on the annualised basis (in practice filed quarterly):

• Numerator: ₹95 crore × ₹13.5 crore ÷ ₹120 crore = ₹10.69 crore
• Less: Tax payable on inverted-rated supply ₹11.4 crore — but here the inversion is mild and the formula yields a small positive
• Practical refund per period is computed monthly/quarterly with the actual input mix; over the full year the cumulative refund claim lands at approximately ₹2.4 crore

The split across four quarterly RFD-01 filings — each tied to its own GSTR-2B reconciliation, GSTR-3B Net ITC ledger, statement 1A HSN summary, and ARN — produces the running file. A deficiency memo on any one quarter shifts that quarter’s refund into the next sanction cycle but does not pause the 2-year clock on the underlying tax periods.

Circular 79/53/2018 and what changed afterwards

Circular 79/53/2018 (issued December 2018) standardised the documentary requirements for inverted-duty refund applications: a self-declaration on unjust enrichment, copies of GSTR-2A/2B for the relevant period, a statement of inverted-rated invoices, the Net ITC computation worksheet, and copies of the GSTR-3B for the period. Circular 125/44/2019 (November 2019) introduced fully electronic refund processing through the GST portal — eliminating manual submission and standardising the RFD-01 → RFD-06 flow. Circular 135/05/2020 (March 2020) restricted the refund of input services and capital-goods ITC under the inverted-duty route, reinforcing the Net ITC definition. The 2022 amendment to Rule 89(5) introduced the proportional input-services netting in the formula itself.

For the current procedural framework, the formula explanation, and the live list of forms, refer to the Central Board of Indirect Taxes and Customs (CBIC).

The reconciliation rails behind a clean RFD-01

A pharma inverted-duty refund file is only as defensible as the underlying reconciliations. Five rails sit underneath every quarterly filing:

Rail 1 — GSTR-2B against API purchase register

Every API and excipient GRN must tie to a vendor invoice that appears in GSTR-2B for the period. Invoices not appearing in GSTR-2B — supplier filing late, supplier filing in the wrong period, or supplier reporting at the wrong GSTIN — cannot be included in Net ITC for the refund period. The reconciliation surfaces missing-in-2B invoices weekly so the supplier can be chased before the refund period closes.

Rail 2 — Procurement route segregation

Every API GRN must carry a procurement-route tag — domestic, import (Bill of Entry), SEZ supplier (with endorsed invoice), or deemed-export. Only domestic, import and SEZ-procured API ITC enters the refund-eligible Net ITC pool. Deemed-export invoices are excluded because the refund vests with the supplier under Section 147 read with Notification 48/2017-Central Tax.

Rail 3 — Net ITC split

The books must maintain a three-way ITC split — inputs, input services, capital goods — so the Rule 89(5) Net ITC line is computed without manual rework at filing time. The post-2022 proportional netting for input services requires a turnover-weighted calculation that the system must apply consistently across periods.

Rail 4 — Adjusted Total Turnover

Total turnover in the state for the period, less exempt supplies (other than zero-rated) and turnover of services, less deemed-export turnover where the supplier has claimed the refund. The line must reconcile to GSTR-1 Table 4/5/6/7 and GSTR-3B Table 3.1.

Rail 5 — Tax overlay and TDS interactions

The pharma manufacturer’s working-capital management also runs through Section 393 contractor TDS on job-work (loan licensing, third-party manufacturing) at payment code 1001 / 1002 (replacing legacy Section 194C), Section 393 professional/technical TDS at codes 1006 / 1010 (replacing 194J) on regulatory consultants and stability-study vendors, and Section 413 / payment code 1071 TCS on scrap (broken glass, expired-batch residuals, packaging waste). See TDS payment codes 1001-1092 India for the full code map. Cross-era invoices raised before 1 April 2026 will carry legacy section references that the reconciliation must keep linked to the new codes for at least one full tax-year cycle.

What automated reconciliation changes

Manual inverted-duty refund preparation across the five rails is a 5-7 day quarterly exercise at a multi-plant formulator, and deficiency memos surface after filing rather than before. Purpose-built GST reconciliation software treats GSTR-2B match, procurement-route tagging, Net ITC split, and Adjusted Total Turnover computation as structured streams and locks the RFD-01 statement before submission. TransactIG carries presets for pharma inverted-duty refunds including the post-2022 proportional input-services netting, the procurement-route segregation, and the ARN-level form-trail tracker through RFD-02 → RFD-03 → RFD-06 → RFD-05. Customer outcomes include match-rate improvement from 51% to 88%, and refund cycle time compression as deficiency memos drop sharply post-implementation. Build is two-to-four weeks on AWS Mumbai (ISO 27001:2022). For the broader month-end stack see reconciliation software India.

Continue reading in the pharma cluster

• Pharma expiry returns — saleable vs non-saleable reconciliation — the credit-note and replacement chain on expired and near-expiry inventory returned by stockists.
• Pharma distributor and stockist reconciliation in India — secondary-sales, scheme-discount and primary-secondary tie-out across the C&F-stockist-retailer chain.
• Pharma R&D weighted-deduction Section 35(2AB) reconciliation — DSIR-approved in-house R&D facility expenditure tracking against the weighted-deduction window.